FIBROUS DYSPLASIA OF BONE
Clinical trials for FIBROUS DYSPLASIA OF BONE explained in plain language.
Never miss a new study
Get alerted when new FIBROUS DYSPLASIA OF BONE trials appear
Sign up with your email to follow new studies for FIBROUS DYSPLASIA OF BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare bone disease: drug raises low phosphate levels
Disease control CompletedThis study tested a drug called burosumab in 12 people with fibrous dysplasia, a rare bone disorder that can cause weak bones and low blood phosphate. The goal was to see if the drug could safely bring phosphate levels back to normal. Participants injected the drug at home once o…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
New hope for rare bone disease pain?
Symptom relief CompletedThis study tested a drug called tocilizumab for people with fibrous dysplasia of bone who still had pain after standard treatment. The drug blocks a protein linked to bone damage. Nineteen adults took part in this small, early-stage trial to see if the drug could reduce bone pain…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated May 17, 2026 08:16 UTC
-
Scientists hunt for MicroRNA clues in rare bone disease
Knowledge-focused CompletedThis study looked at 24 adults with fibrous dysplasia, a rare bone disease that causes pain, fractures, and deformities. Researchers wanted to find out if small molecules called microRNAs in the blood and bone tissue are linked to how severe the disease is. They compared samples …
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC